department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

TACROLIMUS · pharmadog

pharmadog
drugs
TACROLIMUS

drug · small molecule

patient view →

TACROLIMUS

Phase 2updated 2mo ago

by $LIPO LIPELLA PHARMACEUTICALS INC.🔗 ChEMBL

Phase 2

community read0 votes

Small molecule drug with a maximum clinical stage of Approval (across all indications), with 9 approved and 18 investigational indications.

targets

Peptidyl-prolyl cis-trans isomerase FKBP1A

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

brand

TACROLIMUS

trade names

Adoport, Advagraf, Astagraf xl, Capexion, Envarsus, Envarsus xr

generic

TACROLIMUS

MOA

FK506-binding protein 1A inhibitor

indication

Hemorrhagic Cystitis (Haemorrhagic Cystitis)

phase

phase_2

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

ClinicalTrials.gov · OpenTargets

last refreshed 50m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

🐶 often sniffed alongside

top 5

companyAstellas Pharma Inc4 co-mentions · 2 sources
companyAstellas Pharma US Inc4 co-mentions · 2 sources
drugLP-3104 co-mentions · 2 sources
tagRecall2 co-mentions · 2 sources
drug386572 co-mentions · 2 sources

Trials studying TACROLIMUS

phase3A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitorrecruitingn=636
phase3A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)recruitingn=180
phase2Tacrolimus Ophthalmic Solution for the Treatment of Non-infectious Anterior Uveitisrecruitingn=20
phase3A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantationrecruitingn=526
phase2Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinibactive not recruitingn=305
phase2Cytokine Induced Memory-like NK Cell Adoptive Therapy After Haploidentical Donor Hematopoietic Cell Transplantationactive not recruitingn=60
phase3Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)recruitingn=176
phase1Ruxolitinib With Azacitidine Maintenance for the Treatment of Patients With Acute Myeloid Leukemia Undergoing Reduced Intensity Allogeneic Stem Cell Transplantationnot yet recruitingn=40

more trials →